-induced thrombocytopenia (CIT) in non–small cell lung cancer (NSCLC) and data in Chinese patients is sparse, we performed a study on gemcitabine-based CIT in Chinese patients with NSCLC. In this study, we examined the main risk factors in this patient population with the
Search Results
Manish A. Shah and David P. Kelsen
emerged in epidemiologic studies over the past several decades: gastric cardia/gastroesophageal junction (GEJ) tumors. 6 , 7 Table 1 provides a summary of commonly identified risk factors for the development of gastric cancer categorized by disease
Daenielle Lang and Kristen K. Ciombor
that will impact potential outcomes; and (4) unique challenges facing this patient population. Epidemiology and Risk Factors Similar to CRC as a whole, the incidence of rectal cancer in all ages has been decreasing since the 1980s; it has
Sarah T. Le, Pritesh S. Karia, Beverley J. Vollenhoven, Robert J. Besaw, Colleen M. Feltmate, and Chrysalyne D. Schmults
space invasion, margin distance, and clitoral involvement. 6 – 14 Due to inconsistent definitions and results across studies, most risk factors have not been adopted into current staging systems. The vulvar cancer staging system in the 8th edition of
Corbin D. Jacobs, Daniel J. Rocke, Russel R. Kahmke, Hannah Williamson, Gita Suneja, and Yvonne M. Mowery
-defined risk factors (positive margin, lymphovascular invasion, pT3–4, N2–3, extranodal extension, or level IV/V nodal metastasis), and unknown/missing NCCN risk factor data. Log-rank test stratified by RT and Cox regression analyses with respect to OS were
Nirmala K. Manjappachar, John A. Cuenca, Claudia M. Ramírez, Mike Hernandez, Peyton Martin, Maria P. Reyes, Alba J. Heatter, Cristina Gutierrez, Nisha Rathi, Charles L. Sprung, Kristen J. Price, and Joseph L. Nates
; APL, acute promyelocytic leukemia; CLL, chronic lymphocytic leukemia; CML, chronic myeloid leukemia; GVHD, graft-versus-host disease; MM, multiple myeloma. Figure 3. Multivariable analysis of risk factors associated with 28-day mortality (n=456
Therese B. Bevers, Deborah K. Armstrong, Banu Arun, Robert W. Carlson, Kenneth H. Cowan, Mary B. Daly, Irvin Fleming, Judy E. Garber, Mary Gemignani, William J. Gradishar, Helen Krontiras, Swati Kulkarni, Christine Laronga, Loretta Loftus, Deborah J. MacDonald, Martin C. Mahoney, Sofia D. Merajver, Ingrid Meszoely, Lisa Newman, Elizabeth Pritchard, Victoria Seewaldt, Rena V. Sellin, Charles L. Shapiro, and John H. Ward
the United States in 2010. 1 Risk factors for the development of breast cancer can be grouped into categories, including familial/genetic factors (family history, known or suspected BRCA1/2, TP53, PTEN , or other gene mutation associated with breast
Jeffrey Crawford, Pamela Sue Becker, James O. Armitage, Douglas W. Blayney, Julio Chavez, Peter Curtin, Shira Dinner, Thomas Fynan, Ivana Gojo, Elizabeth A. Griffiths, Shannon Hough, Dwight D. Kloth, David J. Kuter, Gary H. Lyman, Mary Mably, Sudipto Mukherjee, Shiven Patel, Lia E. Perez, Adam Poust, Raajit Rampal, Vivek Roy, Hope S. Rugo, Ayman A. Saad, Lee S. Schwartzberg, Sepideh Shayani, Mahsa Talbott, Saroj Vadhan-Raj, Sumithira Vasu, Martha Wadleigh, Peter Westervelt, Jennifer L. Burns, and Lenora Pluchino
-Hodgkin's lymphoma (NHL) has shown that the rates of myelosuppression and delivered dose intensity are underreported. 4 Due to individual patient risk factors, the rates of myelosuppression with the same or similar regimens varied greatly, making it difficult to
Presenters: Valencia D. Thomas, Michael K. Wong, and Andrew J. Bishop
, provide an outline for patient stratification based on risk factors for local recurrence, metastases, and death from disease ( Figure 1 ). 2 “There are so many characteristics and elements that we must take into consideration that there are conflicting
Anne M. Covey
have a known risk factor, 11 and we believe that implementing screening programs for those known populations improves OS. Other risk factors in the setting of HCV cirrhosis include male sex, coinfection with HIV or HBV, older age, diabetes, and obesity